A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples